Latest Breaking News On - Rx communications group - Page 1 : comparemela.com

Immunic to Participate in Industry and Scientific Conferences in June

/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for.

San diegoUnited statesDen haagZuid hollandWerner gladdinesEdna kaplanJessica breuPaula schwartzInternational conventionImmunic incRx communications groupCommunications of immunicProgram management clinical development operations of immunicExchange commissionContract management groupPrnewswire immunic inc

EQS-News: Immunic AG: Immunic to Participate in Industry and Scientific Conferences in June

Issuer: Immunic AG / Key word(s): Conference Immunic to Participate in Industry and Scientific Conferences in June 28.05.2024 / 12:30 CET/CEST The issuer is solely responsible

Den haagZuid hollandUnited statesSan diegoJessica breuEdna kaplanWerner gladdinesPaula schwartzContract management groupRx communications groupDistribution servicesImmunic incInternational conventionExchange commissionImmunic inc nasdaqCommunications of immunic

NeuroBo Pharmaceuticals DA-1241 in Combination with Semaglutide Improves Liver Fibrosis and Demonstrates Additive Hepatoprotective Effects in Pre-Clinical MASH Models Compared to Either Treatment, Alone

NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases, today announced that pre-clinical data suggests that DA-1241, a novel G-Protein-Coupled Receptor 119 (GPR119) agonist,.

United kingdomMonika lewinskaSujin leeHenrikb hansenMarshallh woodworthAhyoung kimMichael feighHoon jungMi kyung kimYuna chaeMichael millerNeurobo pharmaceuticalsDonga st research centerMembers of the donga st research centerContract research organizationExchange commission

EQS-News: Immunic AG: Immunic, Inc Reports First Quarter 2024 Financial Results and Provides Corporate Update

EQS-News: Immunic AG: Immunic, Inc Reports First Quarter 2024 Financial Results and Provides Corporate Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesDaniel vittEdna kaplanJessica breuPaula schwartzTrademark officeExchange commissionImmunic inc nasdaqClinical development programsAmericas committee for treatmentDevelopment rd expensesImmunic incRx communications groupDistribution servicesResearch in multiple sclerosisInterim statement

Immunic, Inc Reports First Quarter 2024 Financial Results and Provides Corporate Update

Immunic, Inc Reports First Quarter 2024 Financial Results and Provides Corporate Update
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesEdna kaplanJessica breuPaula schwartzDaniel vittTrademark officePrnewswire immunic inc nasdaqExchange commissionDevelopment rd expensesAmericas committee for treatmentClinical development programsRx communications groupResearch in multiple sclerosisImmunic incSubstantially bolstered balance sheet throughExtending cash runway into